跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
MAGNESIUM SULFATE BAXTER READY TO USE magnesium sulfate heptahydrate 4 g/100 mL injection for intravenous infusion bag - TGA Drug Approval Details
Approvals
/
TGA
/
MAGNESIUM SULFATE BAXTER READY TO USE magnesium sulfate heptahydrate 4 g/100 mL injection for intravenous infusion bag
Approved
STANDARD
MAGNESIUM SULFATE BAXTER READY TO USE magnesium sulfate heptahydrate 4 g/100 mL injection for intravenous infusion bag
Baxter Healthcare Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
8bdb7c2135b594a6
Company
Baxter Healthcare Pty Ltd
Type
Standard
Approval Details
Approval Id
8bdb7c2135b594a6
Product Name
MAGNESIUM SULFATE BAXTER READY TO USE magnesium sulfate heptahydrate 4 g/100 mL injection for intravenous infusion bag
Artg Id
410016
Artg Name
MAGNESIUM SULFATE BAXTER READY TO USE magnesium sulfate heptahydrate 4 g/100 mL injection for intravenous infusion bag
Sponsor
Baxter Healthcare Pty Ltd
Company Detail Path
/organization/baxter-healthcare-pty-ltd
Artg Date
2024-03-28
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2024-CMI-01544-1
Product Information
http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2024-PI-01543-1
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
8bdb7c2135b594a6
Type
Standard
Back to TGA Approvals